{"id":148181,"date":"2022-01-03T01:57:04","date_gmt":"2022-01-03T01:57:04","guid":{"rendered":"https:\/\/labinsights.com\/acf_article\/chasing-the-invisible-and-the-future-of-the-clinical-lab-qa-with-dr-thomas-grogan-part-3\/"},"modified":"2026-02-11T11:53:00","modified_gmt":"2026-02-11T11:53:00","slug":"chasing-the-invisible-and-the-future-of-the-clinical-lab-qa-with-dr-thomas-grogan-part-3","status":"publish","type":"acf_article","link":"https:\/\/labinsights.com\/RU_ru\/operations\/histopathology\/the-invisible-and-the-future-of-the-clinical-lab-qa-with-dr-thomas-grogan-part-3\/","title":{"rendered":"\u2018Chasing the Invisible\u2019 and the future of the clinical lab: Q&#038;A with Dr Thomas Grogan (Part 3)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"148181\" class=\"elementor elementor-148181 elementor-90840\" data-elementor-post-type=\"acf_article\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9dcc52a e-flex e-con-boxed e-con e-parent\" data-id=\"9dcc52a\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2af78440 elementor-widget elementor-widget-text-editor\" data-id=\"2af78440\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"text-align-justify\">In 2019, Dr Thomas Grogan published <em>Chasing the Invisible<\/em>, a memoir about his experience in launching, scaling and selling Ventana Medical Systems, a pioneer and leading provider of automated instruments for tissue diagnosis.<\/p><br><p class=\"text-align-justify\">In the third instalment of this three-part series on Dr Grogan\u2019s life and career, we explore some of the key lessons from his book and his hopes for the future of laboratory medicine.<\/p><br><p class=\"text-align-justify\">Watch the full Q&amp;A below (<em>click the buttons on the play bar to jump to any specific segment that interests you<\/em>).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>In 2019, Dr Thomas Grogan published Chasing the Invisible, a memoir about his experience in launching, scaling and selling Ventana Medical Systems, a pioneer and leading provider of automated instruments for tissue diagnosis. In the third instalment of this three-part series on Dr Grogan\u2019s life and career, we explore some of the key lessons from [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":139803,"parent":0,"menu_order":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"no-sidebar","site-content-layout":"","ast-site-content-layout":"full-width-container","site-content-style":"unboxed","site-sidebar-style":"unboxed","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"tags":[11374,11357,11659,11380,11662,11412],"pillarandcategory":[318,282,306,301,300,287,309],"reporter":[11601],"class_list":["post-148181","acf_article","type-acf_article","status-publish","has-post-thumbnail","hentry","tag-c-suite-perspectives-ru_ru","tag-healthcare-transformation-ru_ru","tag-leaders-in-conversation-ru_ru","tag-oncology-ru_ru","tag-united-states-ru_ru","tag-11412","pillarandcategory-histopathology","pillarandcategory-disease-area","pillarandcategory-healthcare-transformation","pillarandcategory-leaders-in-conversation","pillarandcategory-management","pillarandcategory-oncology","pillarandcategory-operations","reporter-thomas-grogan"],"acf":[],"_links":{"self":[{"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/acf_article\/148181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/acf_article"}],"about":[{"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/types\/acf_article"}],"author":[{"embeddable":true,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":1,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/acf_article\/148181\/revisions"}],"predecessor-version":[{"id":148182,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/acf_article\/148181\/revisions\/148182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/media\/139803"}],"wp:attachment":[{"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/media?parent=148181"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/tags?post=148181"},{"taxonomy":"pillarandcategory","embeddable":true,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/pillarandcategory?post=148181"},{"taxonomy":"reporter","embeddable":true,"href":"https:\/\/labinsights.com\/RU_ru\/wp-json\/wp\/v2\/reporter?post=148181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}